Lasonolide compounds as reagents for inducing premature chromosome condensation and methods for treating disorders
US8278100B2 · kind B2 · utility
0Cited by
7References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 28, 2009 |
| Grant date | Oct 2, 2012 |
| Priority date | — |
| Expiry date | Apr 30, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed towards lasonolide derivatives, methods of inducing premature chromosome condensation using lasonolide derivatives, and methods of treating disorders, such as cancer, in a subject, the method comprising administering to the subject a lasonolide derivative.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.